Convergence Investment Partners’s AMAG Pharmaceuticals, Inc. AMAG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | – | Sell |
-18,412
| Closed | -$280K | – | 391 |
|
2018
Q4 | $280K | Buy |
+18,412
| New | +$280K | 0.06% | 261 |
|
2017
Q2 | – | Sell |
-50,182
| Closed | -$1.13M | – | 421 |
|
2017
Q1 | $1.13M | Buy |
50,182
+17,412
| +53% | +$393K | 0.16% | 231 |
|
2016
Q4 | $1.14M | Buy |
+32,770
| New | +$1.14M | 0.16% | 250 |
|
2015
Q4 | – | Sell |
-28,356
| Closed | -$1.13M | – | 408 |
|
2015
Q3 | $1.13M | Buy |
+28,356
| New | +$1.13M | 0.13% | 242 |
|
2015
Q1 | – | Sell |
-16,492
| Closed | -$703K | – | 434 |
|
2014
Q4 | $703K | Buy |
+16,492
| New | +$703K | 0.09% | 292 |
|